Cybersecurity and Global Data Privacy Attorney
- Other Business Formation Matter
- SaaS Agreement
- Terms of Service
- User Agreement
- Vendor Agreement
- Other Mergers & Acquisitions Matter
"Soon after XPAN started their firm, I retained their services for a complete evaluation of my firm's cybersecurity policy and procedures. They have exceeded my expectations and now I feel confident that through their efforts I have a more secure cybersecurity environment."
Posted on Oct 27, 2017
Posted on Oct 24, 2017
XPAN Law Group, LLC
Co-Founder & Managing Partner
Jun 2017 - Present
Jordan has extensive experience in the intersection of law and technology. Jordan provides legal advice in cross-border data transfer issues, with a special emphasis in European Union data privacy regulations and the forthcoming General Data Protection Regulation. Jordan regularly evaluates and assesses data opportunities and risks to aid clients in secure and compliant information governance.
Thomas R. Kline School of Law at Drexel University
Jan 2015 - Present
Jordan is an Adjunct Professor at the Thomas R. Kline School of Law, focusing on international law. Jordan teaches a range of courses, including European Union law, introduction to U.S. legal systems, and civil and common law comparative studies.
Archer & Greiner
Dec 2013 - Jun 2017
Jordan was an associate in the Business Litigation Group and the Data Privacy and Cybersecurity Group representing companies, government agencies, and individuals in complex commercial disputes and constitutional litigation. Jordan regularly evaluated and assessed legal and business opportunities and risk to provide public and private clients with critical legal assessments and strategy.
Court of Justice of the European Union
Sep 2013 - Nov 2013
Jordan was selected as the stagaire (judicial law clerk) for now-President Koen Lenaerts for the Fall 2013 term. Jordan researched EU legal issues to draft and prepare memoranda in both English and French on a variety of legal issues including financial tax transactions, interim relief, and pharmaceutical patents.